New dissolvable tablet could make taking medication easier

NCT ID NCT07297199

Completed Knowledge-focused Sponsor: Biogen Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a tablet that dissolves in liquid works the same as the capsule form of the drug omaveloxolone (SKYCLARYS). The drug is already approved for Friedreich's ataxia, but some people have trouble swallowing capsules. Seventy healthy adults took both forms in random order, with a two-week break in between. Researchers measured how the drug moved through the body and checked for side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Omaveloxolone (also known as BIIB141 or SKYCLARYS)
What this could lead to: If successful, this study could show that the tablet form works as well as the capsule, offering an easier way for people who have trouble swallowing capsules to take this medication.
What could go wrong: This is an early-phase study in healthy volunteers, not patients. It only checks how the drug is processed, not whether it works for any disease. Results may not apply to people with medical conditions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY VOLUNTEER

Contacts and locations

Locations

Trialmed formerly PPD, Austin Clinical Research Unit

Austin, Texas, 78744, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.